Posters
« Back
MicroRNA Expression Signature in Human Glioblastoma Multiforme Brain Tumor
EP20204
Poster Title: MicroRNA Expression Signature in Human Glioblastoma Multiforme Brain Tumor
Submitted on 19 Dec 2013
Author(s): Dana Ridzon, Ruoying Tan, Julie Nguyen, Adam Broomer, Caifu Chen
Affiliations: Applied Biosystems
Poster Views: 1,237
View poster »


Poster Information
Abstract: Expression of 180 human miRNAs was examined using recently developed stem loop primers for reverse transcription (RT) followed by real-time PCR. MicroRNAs can be quantified from as few as single cells or as little as 25 pg total RNA. The CT values correlated to the copy number over up to seven orders of magnitude. TheTaqMan® miRNA assays discriminated between two miRNAs that differed by as little as a single nucleotide, and between mature miRNAs and their precursors.

This method allows accurate and sensitive miRNA expression profiling and uncovers precise changes of miRNA expression. Comparing to normal human brain, the glioblastoma multiforme (GBM) tumors have a distinct expression signature of miRNAs. Nearly half of miRNAs showed the reduced expression by > 2-folds. In contrast, only 13% miRNAs had increased expression (>2-folds) in GBM. Expression of miR-10a and miR-10b etc. located within class I HOX and miR-129, miR-139,and miR-153 etc. within class II HOX gene clusters is either elevated or reduced (>10-fold), suggesting that these miRNAs may be involved in brain cancers.
Summary: Expression of 180 human miRNAs was examined using recently developed stem loop primers for reverse transcription (RT) followed by real-time PCR. MicroRNAs can be quantified from as few as single cells or as little as 25 pg total RNA.Report abuse »
Creative Commons

Related Posters


Genome Wide Profiling of Histone Modifications with ChIP Seq
CD Genomics

Health vision 2030: An Era of Evolution and Revolution in India
GAURAV JAIN

miniaturization and automation of CEL-Seq2 and SMART-Seq2 using the mosquito liquid handler
Josip Herman1, Jon Penterman2, Sagar1, Andreas Diefenbach3, Antigoni Triantafyllopoulou4, Anne F. Hammerstein5, Joby Jenkins5, Dominic GrĂ¼n1, Stuart S. Levine2 and Klaus Hentrich5

Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt

Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy